Skip to content

ProLy-Study: Preventing lymphoceles using a peritoneal flap fixation in robot-assisted radical prostatectomies – a prospective multicenter RCT

ProLy-Study: Preventing lymphoceles using a peritoneal flap fixation in robot-assisted radical prostatectomies – a prospective multicenter RCT - ProLy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015720
Enrollment
828
Registered
2019-09-26
Start date
2018-11-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I89.8 C61

Interventions

Group 1: Robotic-assisted radical prostatectomy (RARP) with extended pelvic lymph node dissection (PLND) with bilateral standardized formation of a peritoneal-flap next to the field of PLND Group 2: R

Sponsors

Klinik für Urologie und Zentrum für minimal-invasive und robotisch-assistierte Urologie Augusta Bochum Akad. Lehrkrankenhaus der Univ. Essen/Duisburg Chefarzt Prof. Dr. med. B. Ubrig für die Deutsche Gesellschaft für roboter-assistierte Urologie e.V.
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult men with diagnosed localized non-metastatic prostate cancer (max. T2, cN0, cM0) undergoing transperitoneal radical prostatectomy with pelvic lymph node dissection as proposed in German national guidelines, who are able and willing to give written informed consent and to participate in the follow up appointments.

Exclusion criteria

Exclusion criteria: Incapacity to give informed consent (language barrier, cognitive impairment/mental disorders, prisoners) Inadequate compliance for follow up visits Current participation in other clinical trials Previous radiation of abdomen or pelvis (percutaneous/brachy therapy) Previous transurethral treatment of benign prostate hyperplasia Previous chemotherapy within last 5 years Previous abdominal surgery with high risk of adhesions, especially colon surgery, vascular surgery. Uncomplicated cholecystectomy, appendectomy, endoluminal vascular therapie are not excluded Current or previous deep vein thrombosis within 12 months Previous PLND Planned simultaneously hernia surgery Diagnosed coagulation disorder Unexplained pathological lab values or unexplained pathological results in physical exanimation Staff members and their relatives

Design outcomes

Primary

MeasureTime frame
90-days prevalence of lymphoceles

Secondary

MeasureTime frame
size and extend of detected lymphoceles prevalence of symptomatic lymphoceles prevalence of treatment of lymphoceles prevalence of postoperative complications (Clavien-Dindo-Classification) length of procedure

Countries

Germany

Contacts

Public ContactAnselm Boy

Klinik für Urologie und Zentrum für minimal-invasive und robotisch-assistierte Urologie Augusta Bochum Akad. Lehrkrankenhaus der Univ. Essen/Duisburg

a.boy@augusta-bochum.de+ 49 234 517 2651

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026